News

LUCKNOW The department of respiratory medicine at Lucknow’s King George’s Medical University (KGMU) successfully performed whole lung lavage (WLL), a rare and complex procedure, to treat a 45 ...
Interstitial lung diseases (ILDs), also referred to as diffuse parenchymal lung diseases, represent a broad spectrum of disorders marked by lung fibrosis (scarring).
The specific search strategy was: “Extracellular Vesicles” AND [ (Diffuse parenchymal lung disease) OR (Interstitial lung diseases) OR (Idiopathic Pulmonary Fibrosis) OR (Interstitial pneumonia) OR ...
A new lung transplant program at Mayo Clinic is offering renewed hope to patients with advanced lung disease.
The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown cause, and the condition, which turns healthy lung tissue into fibrous ...
However, there is no available information in the literature regarding the prevalence of vitamin D deficiency among patients with diffuse parenchymal lung disease or whether reduced levels are ...
In coal mining communities, black lung has long been considered an “old man’s disease,” one to be almost expected after enough years underground.
Referred to as ‘popcorn lung,’ the obstructive lung condition has been challenging clinicians for decades. But more recent outbreaks are helping to provide better clues for future patients.
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug ...
Sionna's CF drug candidates SION-719 and SION-451 showed strong safety and PK results in Phase 1 trials, advancing to mid-stage studies in 2025.
Transpire Bio has licensed an inhaled PDE4 inhibitor from China’s Intragrand Pharma as a potential treatment for idiopathic pulmonary fibrosis.
A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first.